Truvian Sciences Looks to Disrupt Dx Market With Three-Modality Platform

Theranos sounded too good to be true – and it was. Truvian Sciences has heard the comparisons to Elizabeth Holmes’ company and wants you to know it’s different

Leave a Reply

Your email address will not be published. Required fields are marked *